Compare SUPN & MAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | MAN |
|---|---|---|
| Founded | 2005 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2010 | 1994 |
| Metric | SUPN | MAN |
|---|---|---|
| Price | $47.64 | $56.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 6 |
| Target Price | ★ $61.60 | $35.67 |
| AVG Volume (30 Days) | 958.1K | ★ 1.5M |
| Earning Date | 05-05-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 4.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $392,755,000.00 | ★ $17,957,100,000.00 |
| Revenue This Year | $22.70 | $5.12 |
| Revenue Next Year | $19.14 | $3.42 |
| P/E Ratio | ★ N/A | $1,106.80 |
| Revenue Growth | N/A | ★ 0.58 |
| 52 Week Low | $40.32 | $25.15 |
| 52 Week High | $59.68 | $57.08 |
| Indicator | SUPN | MAN |
|---|---|---|
| Relative Strength Index (RSI) | 50.78 | 69.02 |
| Support Level | $43.43 | $27.11 |
| Resistance Level | $47.55 | $56.39 |
| Average True Range (ATR) | 2.49 | 2.33 |
| MACD | -0.13 | -0.19 |
| Stochastic Oscillator | 41.87 | 78.78 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.